GLP-1 Guide Evidence-first GLP-1 drugs and research compounds like semaglutide, tirzepatide, and retatrutide curb appetite, which can leave gaps in protein and key nutrients
In the small intestine, it increases the secretion of incretin hormones (like GLP-1) in response to nutrient ingestion
Published Results In a peer-reviewed study published in 2025, researchers analyzed 1,131 patients following the IVIM Protocol on semaglutide therapy
If you are taking a related licensed medicine such as semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro), which act on overlapping receptor pathways and are experiencing nausea, it is entirely appropriate to discuss this with your GP or prescriber
Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus
(TIF) S2 File